CDTX(Delisted)
Cidara Therapeutics·NASDAQ
--
--(--)
CDTX fundamentals
Cidara Therapeutics (CDTX) released its earnings on Nov 8, 2017: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Nov 8, 2017
EPS
Revenue
Revenue & Expenses
Key Indicators
Cidara Therapeutics (CDTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Cidara Therapeutics (CDTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Cidara Therapeutics (CDTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cidara Therapeutics (CDTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Cidara Therapeutics (CDTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Cidara Therapeutics (CDTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
